This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
October 13, 2016
GenSight Biologics reports its cash position as of September 30, 2016
October 13, 2016
BrainCool makes a strategic acquisition in purchasing all assets of the American medical cooling company Benechill Inc
October 12, 2016
Nordic Nanovector ASA: Extraordinary General Meeting held
October 12, 2016
Nordic Nanovector announces the appointment of Joanna Horobin, MD, as Non-executive Board Director
October 10, 2016
Aprea Therapeutics Announces First Patients Enrolled in Phase II Clinical Study of APR-246 for the Treatment of High-Grade Serous Ovarian Cancer
October 10, 2016
Aprea Therapeutics Announces Efficacy and Safety Data in High-Grade Serous Ovarian Cancer Patients Treated with APR-246 in Presentation at 2016 European Society for Medical Oncology (ESMO) Annual Meeting
October 10, 2016
Nordic Nanovector and LegoChem Biosciences enter collaboration to develop novel antibody-drug conjugates (ADCs) targeting leukaemias
October 10, 2016
Onxeo to Present at the 15th Annual BIO Investor Forum in San Francisco
October 04, 2016
Mundipharma and Orexo announce EU regulatory submission for Zubsolv®
October 03, 2016
Strongbridge Biopharma plc Announces Appointment of Jeffrey W. Sherman, M.D., FACP, to Board of Directors